
|Articles|May 2, 2003
- Pharmaceutical Technology-05-02-2003
- Volume 27
- Issue 5
Drug Safety in the Limelight
Author(s)Jill Wechsler
FDA resolves the bar code labeling debate, releases its GMP requirements for dietary supplements, and proposes a comprehensive adverse-event reporting system.
Advertisement
Articles in this issue
over 23 years ago
May 2003over 23 years ago
Outsourcing Outlookover 23 years ago
The Square Root of N Plus One Sampling Ruleover 23 years ago
Particle Attrition by Particle?Surface Friction in DryersAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation
2
CAR T-Cell Trial Pause Signals New Manufacturing Risk Review
3
AAPS PharmSci 360: CMC Strategies, Part 1
4
AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 1
5




